Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile.
González-Martín A, Alba E, Ciruelos E, Cortés J, Llombart A, Lluch A, Andrés R, Álvarez I, Aramendía JM, de la Peña FA, Barnadas A, Batista N, Calvo L, Galve E, García-Palomo A, García-Sáenz JÁ, de la Haba J, López R, López-Vivanco G, Martínez-Jáñez N, de Dueñas EM, Plazaola A, Rodríguez-Lescure Á, Ruiz M, Sánchez-Rovira P, Santaballa A, Seguí MÁ, Tusquets I, Zamora P, Martín M. González-Martín A, et al. Among authors: de la pena fa. Curr Cancer Drug Targets. 2016;16(5):415-28. doi: 10.2174/1568009615666150817121731. Curr Cancer Drug Targets. 2016. PMID: 26278712 Review.
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN.
Martínez-Jañez N, Ezquerra MB, Manso Sanchez LM, Carrasco FH, Torres AA, Morales S, Ortega PT, Gil VLO, Sampedro T, Conejero RA, Calvo-Martinez L, Galve-Calvo E, López R, de la Pena FA, Lopez-Tarruella S, de Araguiz BAHF, Ruiz LB, Cardenas TM, Chacon JI, Antón FM. Martínez-Jañez N, et al. Among authors: de la pena fa. Breast Cancer Res Treat. 2024 Apr 1. doi: 10.1007/s10549-024-07287-w. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38561577
The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism.
Jiménez-Fonseca P, Carmona-Bayonas A, Font C, Plasencia-Martínez J, Calvo-Temprano D, Otero R, Beato C, Biosca M, Sánchez M, Benegas M, Varona D, Faez L, Antonio M, de la Haba I, Madridano O, Solis MP, Ramchandani A, Castañón E, Marchena PJ, Martín M, de la Peña FA, Vicente V; EPIPHANY study investigators and the Asociación de Investigación de la Enfermedad Tromboembólica de la Región de Murcia. Jiménez-Fonseca P, et al. Among authors: de la pena fa. Clin Transl Oncol. 2018 Feb;20(2):230-242. doi: 10.1007/s12094-017-1713-3. Epub 2017 Jul 10. Clin Transl Oncol. 2018. PMID: 28695478
Top ten errors of statistical analysis in observational studies for cancer research.
Carmona-Bayonas A, Jimenez-Fonseca P, Fernández-Somoano A, Álvarez-Manceñido F, Castañón E, Custodio A, de la Peña FA, Payo RM, Valiente LP. Carmona-Bayonas A, et al. Among authors: de la pena fa. Clin Transl Oncol. 2018 Aug;20(8):954-965. doi: 10.1007/s12094-017-1817-9. Epub 2017 Dec 7. Clin Transl Oncol. 2018. PMID: 29218627 Review.
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy.
García-Martínez E, Smith M, Buqué A, Aranda F, de la Peña FA, Ivars A, Cánovas MS, Conesa MAV, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. García-Martínez E, et al. Among authors: de la pena fa. Oncoimmunology. 2018 Feb 15;7(6):e1433982. doi: 10.1080/2162402X.2018.1433982. eCollection 2018. Oncoimmunology. 2018. PMID: 29872569 Free PMC article. Review.
12 results